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ABSTRACT
Histone modifications play an important role in epi-
genetic gene regulation and genome integrity. It
remains largely unknown, however, how these modi-
fications dynamically change in individual cells. By
using fluorescently labeled specific antigen binding
fragments (Fabs), we have developed a general
method to monitor the distribution and global level
of endogenous histone H3 lysine modifications in
living cells without disturbing cell growth and em-
bryo development. Fabs produce distinct nuclear
patterns that are characteristic of their target modi-
fications. H3K27 trimethylation-specific Fabs, for
example, are concentrated on inactive X chromo-
somes. As Fabs bind their targets transiently, the
ratio of bound and free molecules depends on the
target concentration, allowing us to measure
changes in global modification levels. High-affinity
Fabs are suitable for mouse embryo imaging, so we
have used them to monitor H3K9 and H3K27 acetyl-
ation levels in mouse preimplantation embryos pro-
duced by in vitro fertilization and somatic cell
nuclear transfer. The data suggest that a high level
of H3K27 acetylation is important for normal embryo
development. As Fab-based live endogenous modi-
fication labeling (FabLEM) is broadly useful for vis-
ualizing any modification, it should be a powerful
tool for studying cell signaling and diagnosis in the
future.
INTRODUCTION
Post-translational protein modiﬁcations play a critical role
in the regulation of many biological processes, like cell me-
tabolism and signaling. These modiﬁcations can change
rapidly and dramatically in response to internal and exter-
nal stimuli, altering the properties of proteins, including
their enzymatic activity, subcellular localization and inter-
molecular interactions (1). Whereas modiﬁcation-speciﬁc
antibodies and mass spectrometry can detect the dynamics
of modiﬁcations in ﬁxed and biochemically isolated
samples, real-time imaging of modiﬁcations in single living
cells is important for understanding their spatiotemporal
regulation (2).
Histones are some of the most highly modiﬁed proteins
in the cell nucleus. Together with DNA they form nucleo-
somes, which are subject to a wide range of modiﬁcations,
including acetylation, methylation and phosphorylation.
These modiﬁcations help regulate gene expression and
maintain genome integrity (3). Transcriptionally active
chromatin is generally associated with histone H3 lysine
acetylation and H3 lysine 4 (H3K4) methylation, whereas
silent chromatin typically harbors methylation on H3
lysine 9 or 27 (H3K9 or H3K27). The levels of histone
modiﬁcations change both locally and globally through-
out the cell cycle, as well as during development and dif-
ferentiation, pathogenesis, and in response to external
stimuli (3,4). For example, immunoﬂuorescence studies
using modiﬁcation-speciﬁc antibodies have shown the
drastic changes in the acetylation and methylation levels
of histone H3 and H4 during mouse embryo development
and germ cell formation (5–7).
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histone modiﬁcations in single living cells, but new devel-
opments are beginning to change this (8). A Fo ¨ rster/ﬂuor-
escence resonance energy transfer (FRET)-based sensor
has been developed to monitor histone H4 diacetylation
in response to histone deacetylase (HDAC) inhibitors (9).
Although this sensor can monitor the balance of modify-
ing and demodifying enzymes, it is unable to detect the
modiﬁcations of endogenous proteins. Concurrently, we
have used ﬂuorescently labeled antigen-binding fragments
(Fabs) to visualize endogenous histone H3 phosphoryl-
ation during the cell cycle (10).
In this study, we demonstrate that the localization and
global level of a variety of different epigenetic modiﬁca-
tions of endogenous histone H3 can be monitored in single
living cells using speciﬁc monoclonal antibodies (mAbs)
(11). Soon after being loaded into the cytoplasm of
living cultured cells, ﬂuorescently labeled Fabs can enter
the nucleus and produce distinct nuclear patterns that are
characteristic of their target modiﬁcations. Fabs bind to
their epitopes transiently in living cells and the binding
time correlates with their in vitro epitope-binding afﬁnity.
Thus, when nuclear modiﬁcation levels increase, so too
does the concentration of nuclear Fabs (since there are
now more target binding sites). It is therefore possible to
monitor rapid changes in global modiﬁcation levels by
simply comparing the concentration of Fabs in the
nucleus and cytoplasm.
Fabs with higher afﬁnities are also suitable for imaging
modiﬁcations in mouse preimplantation embryos without
disturbing normal development. Monitoring H3K9 and
H3K27 acetylation levels in mouse preimplantation em-
bryos revealed their differential behavior. While H3K9
acetylation level remains relatively constant throughout
zygote and two-cell stages, H3K27 acetylation is reduced
drastically in zygotes. Furthermore, the H3K27 acetyl-
ation level in somatic nuclei transferred into oocytes is
much lower than pronuclei in zygotes, but is increased
by histone deacetylase inhibitor treatments, which are
known to improve the cloning efﬁciency of embryos
transferred with somatic nuclei (12). These data suggest
that a high level of H3K27 acetylation is important for
normal embryo development, possibly by counteracting
the methylation on the same site. In general, Fab-based
live endogenous modiﬁcation labeling (FabLEM) can be
used to monitor any endogenous protein modiﬁcation in
single living cells. We therefore anticipate it will ﬁnd many
future applications.
MATERIALS AND METHODS
Antibody and dye-conjugation
To generate monoclonal antibodies directed against his-
tone H3K9me1, H3K9me2, H3K9me3 and H3K27me3,
mice were immunized with synthetic peptide ARTKQ
TAR(me1-K)STGGKAPRKQC, ARTKQTAR (me2-K)
STGGKAPRKQC, ARTKQTAR(me3-K)STGGKAPR
KQC and KQLATKAAR(me3-K)SAPATGGVKC, re-
spectively, coupled to keyhole limpet hemocyanin. After
generating hybridomas, clones were screened by ELISA
using peptides listed in (11). Clones CMA316, CMA317/
6D11, CMA318/2F3 (13) and CMA323 reacted speciﬁcal-
ly with H3K9me1, H3K9me2, H3K9me3 and H3K27me3,
respectively (e.g. Supplementary Figure S1). CMA316 was
isotyped as IgG3-k and the other clones were isotyped as
IgG1-k using a kit (AbD Serotec). For antibody puriﬁca-
tion, hybridomas were grown in CD Hybridoma medium
(Invitrogen) supplemented with 2mM glutamine. Except
CMA316, the culture supernatant (250ml) was ﬁltrated
through a 0.45-mm pore ﬁlter, added with NaCl at a
ﬁnal concentration of 4M and applied to a HiTrap
Protein A HP Sepharose column (1ml; GE Healthcare).
After washing the column with Protein A IgG1 binding
buffer (Thermo Fisher Scientiﬁc), IgG was eluted using
Mouse IgG1 Mild Elution Buffer (Thermo Fisher
Scientiﬁc) and concentrated up to 4–8mg/ml in PBS
using an Amicon Ultra ﬁlter (50k-cut off; Millipore). As
CMA316 was sensitive to low pH elution, it was puriﬁed
through a HiPrep CM Sepharose (GE Healthcare) using a
linear NaCl gradient (20–300mM) in 50mM 2-morpho-
linoethanesulfonic acid butter (pH 6.5), followed by gel
ﬁltration chromatography using HiLoad 16/60 Superdex
200pg (GE Healthcare) in PBS.
The afﬁnity of antibodies to the epitope was measured
by surface plasmon resonance using BIACORE X100
(GE Healthcare Biosciences). The interaction experiments
were performed in PBS, at ﬂow rate of 30ml/min. A 60ml
aliquot of each of the different concentrations of anti-
bodies (1, 4, 16, 64 and 256nM) was injected onto the
chip sequentially without regeneration. Although a
previous ELISA study showed CMA310 cross-reacted
with acetylated H3K27 (H3K27ac) (11), the binding to
H3K27 was several orders of magnitude lower according
to BIACORE measurements (6.2 10
 6 M to H3K27ac
peptide versus 4.4 10
 11 M to H3K9ac; Table 1); thus
CMA310 is now regarded as H3K9ac speciﬁc mAb.
Fab was prepared using a kit (Thermo Fisher Scientiﬁc;
Pierce Fab Preparation Kit or Pierce Mouse IgG1 Fab
and F(ab0)2 Preparation Kit) according to the manufac-
turer’s instruction. After the buffer was replaced to PBS
using PD10 desalting column (GE Healthcare), the sam-
ples were concentrated up to  1mg/ml using an Ultrafree
0.5 ﬁlter (10k-cut off; Millipore). The purity and integrity
Table 1. Epitope-binding afﬁnity of mAbs in vitro by surface
plasmon resonance measurements
mAb
a Peptide
b ka (M
 1s
 1)
c kd (s
 1)
d KD (M)
e
CMA303 H3K4me2 7.6 10
9 8.2 10
1 1.1 10
 8
CMA309 H3K27ac 2.4 10
5 3.4 10
 7 1.4 10
 12
CMA310 H3K9ac 1.6 10
5 6.8 10
 6 4.4 10
 11
H3K27ac 7.5 10
3 4.7 10
 2 6.2 10
 6
CMA317 H3K9me2 1.6 10
9 2.4 10
1 1.5 10
 8
CMA323 H3K27me3 2.6 10
5 3.2 10
 3 1.2 10
 8
amAb analyzed.
bSensor tip was coated with bovine serum albumin conjugated with
indicated peptide.
cAssociation rate.
dDissociation rate.
eDissociation constant (kd/ka).
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gradient gel (Wako). Puriﬁed Fab or IgG was conjugated
with a ﬂuorescent dye using Alexa Fluor 488 tetraﬂuoro-
phenyl ester (Invitrogen), Cy3 N-hydroxysuccinimide ester
(GE Healthcare), or Cy5 N-hydroxysuccinimide ester
(GE Healthcare). Dried ﬂuorescent dye esters (for labeling
1mg protein) were dissolved into 50 (Alexa488) or 100
(Cy3 and Cy5)ml dimethyl sulfoxide (DMSO; Wako)
and stored at  20 C. Fab (100mg) was diluted into
100mM NaHCO3 (pH 8.3) in 100ml. After addition of a
dye solution (5, 1.5 and 4ml for Alexa488, Cy3 and Cy5,
respectively), the mixture was incubated for 1h at room
temperature with gentle rotation. The sample was passed
through a PD-mini G-25 desalting column (GE
Healthcare), which was pre-equilibrated with PBS, to
remove unconjugated dyes, and dye-conjugated Fab was
concentrated up to  1mg/ml using an Ultrafree 0.5 ﬁlter
(10k-cut off; Millipore). The Fab concentration and
dye:protein ratio were calculated from the absorbance at
280 and 494, 552, or 650nm, using the extinction coefﬁ-
cient of IgG and correction factor at 280nm provided by
the manufacturers (i.e. 0.11, 0.08, or 0.05). Fluorescent
dye-labeled Fab samples that yielded dye:protein ratio
 1–2 were used for live imaging.
Puriﬁed recombinant PCNA (14) was conjugated with
Cy3 as described above (0.6mg/ml; dye:protein ratio 0.3).
Cells and microscopy
Somatic cells were routinely grown in DME (Dulbecco’s
modiﬁed Eagle’s medium; Sigma-Aldrich) supplemented
with penicillin/streptomycin (10U/ml penicillin, 50mg/ml
streptomycin; Sigma-Aldrich) and 10% FCS. Skin ﬁbro-
blasts derived from normal female (WI-38; passage 14),
Klinefelter Syndrome (Detroit 529; passage 14 and
Dempsey; passage 25) and Turner Syndrome (Detroit
525; passage 22) were purchased from American Type
Culture Collection. HeLa and U2OS cells have been
described previously (10). HeLa cells stably expressing
histone H2B-mRFP were established by transfecting an
H2B-mRFP expression construct (15,16). Conditional
G9a knockout ES cells based on Mer-Cre-Mer system
(17) were cultured in DME (Nacalai Tesque) supple-
mented with leukemia inhibitory factor (1000U/ml;
Invitrogen), non-essential amino acids, sodium pyruvate,
2-mercaptoethanol, penicillin/streptomycin and 10%
FCS. To delete the G9a gene, ES cells were cultured in
800nM 4-hydroxytamoxifen (Sigma-Aldrich) for 4 days.
For live cell imaging, cells were plated on a glass-
bottom dish with a coverslip (Mat-Tek) and the next
day ﬂuorescent Fab was loaded using a bead-loading
method (10,18,19), as follows. The medium was removed
from the dish, ﬂuorescent Fab was pipetted onto the center
of the coverslip (1mg/ml in PBS; 2–4ml), and glass beads
(106mm; Sigma-Aldrich; G-4649) were sprinkled on top.
After tapping the dish four to eight times, DME was im-
mediately added to the dish and beads were washed away.
The medium was then replaced to phenol red-free DME
(Nacalai Tesque) containing the supplements. The dish
was placed either on an inverted microscope (Ti-E; Nikon)
or on a confocal microscope (FV-1000; Olympus).
Either microscope featured a culture system (Tokai Hit)
at 37 C under 5% CO2. Wide-ﬁeld ﬂuorescence images
were captured using a Ti-E (Nikon) under the operation
of NIS Elements ver 3.0 (Nikon) with a PlanApo VC  100
(NA=1.4) oil-immersion objective lens equipped with an
electron multiplying charge-coupled device (iXon+;
Andor; normal mode; gain  5.1) with ﬁlter sets
(Semrock; LF488-A for Alexa488, LF561-A for Cy3 and
Cy5-4040A for Cy5); the exposure period was set to
100–1000ms. A 75W Xenon lamp was used as a light
source and attenuated through neutral-density and
440nm long-pass ﬁlters to achieve a light intensity of
6–10mW at the specimen. Phase-contrast images were
also collected (100ms) using an external phase ring. In
some cases, three different focal planes were imaged with
2mm intervals. For Figure 3A–D and Supplementary
Figure S2, optical sections were collected using an
FV-1000 (Olympus) with a PlanSApo 60  (NA=1.35)
oil-immersion lens (512 512 pixels; 10ms/pixel; four-
line Kalman; pinhole 120mm). Multicolor ﬂuorescence
images were collected using line sequential mode, and
differential interference contrast images were collected
simultaneously with Alexa488 images (Figure 3C).
For Immunoﬂuorescence using ﬁxed samples, cells
grown on coverslips were ﬁxed with 1% formaldehyde
(Electron Microscopy Sciences) in 250mM HEPES–
NaOH (pH 7.4) for 10min at room temperature, washed
with PBS, incubated in 2mg/ml Cy3-conjugated IgG and
10ng/ml Hoechst 33342 (Nacalai Tesque) in PBS contain-
ing 10% Blocking One-P (Nacalai Tesque) and 0.5%
Triton X-100 for 2h at room temperature. After
washing three times with PBS, coverslips were mounted
using Prolong-Gold (Invitrogen). Fluorescence images
were sequentially collected using a confocal microscope
(FV-1000; Olympus; operated by the built-in software
ver. 1.7) as above.
FRAP was performed using a confocal microscope
(FV-1000; Olympus) with a PlanSApo 60  (NA=1.35)
oil-immersion lens (10). For Figure 2, 10 images were col-
lected (0.4% 488-nm laser transmission; 1s/frame; 2ms/pixel;
256 256 pixels; pinhole 800mm; 6  zoom), a 2mm diam-
eter spot was bleached (100% 488-nm laser transmission;
four iteration), and a further 90 images were collected
using the original settings. For Supplementary Figure S5,
10 images were collected (0.3% 488-nm and 3% 543-nm
laser transmission; 0.38s/frame; 2ms/pixel; 128 128
pixels; pinhole 800mm; 10  zoom), a 2mm diameter spot
was bleached (25% 405-nm, 100% 488-nm and 100%
543-nm laser transmission; 53ms), and a further 290
images were collected using the original settings. To
quantify the bound/free fraction, the pure-diffusion coef-
ﬁcient of each Fab was required. For this purpose, meas-
urements of diffusion in the cytoplasm were made. To
monitor fast diffusion, a single line (0.8% 488-nm and
39% 543nm laser transmission; 2ms/pixel; 128 1 pixels;
pinhole 800mm; 10  zoom) passing through the center of
the bleach spot (2mm diameter, 100% 405-nm laser trans-
mission; 77ms) was continually scanned to quantify the
bleach spot proﬁle with time. 100 pre-bleach scans were
followed by 2000 post-bleach scans.
Nucleic Acids Research, 2011,Vol.39, No. 15 6477Fluorescence intensity was measured using Metamorph
ver 7.5 (Molecular Devices) and plotted using Origin ver 7
(OriginLab). Mathematica (Wolfram Research) was used
for the ﬁtting analysis in Supplementary Figure S5.
Imaging mouse preimplantation embryos
Mouse oocyte preparation, in vitro fertilization (IVF),
microinjection, and imaging were described previously
(10,20). Brieﬂy, fertilized oocytes at anaphase
II-telophase II stage were injected with a mixture of
ﬂuorescently-labeled Fab and 5mg/ml of histone
H2B-mRFP1 mRNA and placed on the imaging system
(Figure 6A and B). For the imaging of the SCNT
embryos, metaphase II stage oocytes were injected with
the above mixture, enucleated and injected with a
somatic nucleus derived from a cumulus cell. The recon-
structed embryos were artiﬁcially activated with Ca
2+-free
Chatot-Ziomek-Bavister medium containing 10mM SrCl2
and 5mg/ml cytochalasin B in the presence or absence of
50nM TSAfor 6h. Accordingto the original protocol (12),
the embryos were further incubated for 3h in the presence
of 50nM TSA. As an imaging system, an inverted micro-
scope (IX-71; Olympus) with UPlanApochromat 20 
(NA=0.8) oil-immersion lens was attached with a
Nipkow-disk scanning confocal unit (CSU10; Yokogawa
Electric Corp.) and an electron multiplying charge-coupled
device (iXON BV-887; Andor). Three-dimensional and
multipoint acquisition of images were performed using a
z motor (Mac5000; Ludl Electronic Products) and an auto-
xy stage (Sigma Koki). MetaMorph ver 7.5 (Molecular
Devices) was used for device control and image analysis.
Fifty-one images in the z-axis and two color images
(excited with 488- and 561-nm laser lines) were captured
at 15min intervals. After the imaging, morula–blastocyst
stage embryos produced by IVF were transferred to the
uterus of the recipient pseudopregnant mothers. All
animals were maintained in accordance with the Animal
Experimental Handbook at the Kobe Center for
Developmental Biology (RIKEN).
RESULTS
Visualizing acetylated histone H3 in living cells using a
speciﬁc monoclonal antibody
To visualize protein modiﬁcations in living cells, puriﬁed
monoclonal antibody (mAb), either as a form of immuno-
globulin G (IgG) or Fab, was conjugated with a ﬂuores-
cent dye and loaded into cells (Figure 1A). If the antibody
speciﬁcally binds to nuclear protein modiﬁcations, it
should localize to regions of chromatin that are enriched
in that modiﬁcation. We ﬁrst used acetylated histone
H3K9 (H3K9ac)-speciﬁc mAb CMA310 (11) (Table 1)
to compare the properties of IgG (IgGH3K9ac) and Fab
(FabH3K9ac). When loaded into the cytoplasm of HeLa
cells at  1mM by bead-loading (10), Alexa Fluor
488-labeled IgGH3K9ac was excluded from the nucleus
because it could not pass through the nuclear pore due
to its large size ( 150kD). Only during mitosis, when
the nuclear membrane breaks down, could IgGH3K9ac
access target chromatin and be incorporated into the
nucleus in daughter cells (Figure 1B and Movie 1 in
Supplementary Data). In contrast, Alexa Fluor
488-labeled H3K9ac-speciﬁc Fab (FabH3K9ac-488) im-
mediately diffused into the nucleus due to its smaller
size ( 50kD) and exhibited nucleoplasmic concentra-
tions in less than an hour (Figure 1C and Movie 2 in
Supplementary Data). Hence, Fab appears to be more con-
venient than the whole IgG molecule for live-cell imaging.
The monovalency of Fab may also be an advantage,
because the divalent IgG could form artiﬁcial aggregations
when two antigens are bridged (21).
To validate whether FabH3K9ac is indeed targeted to
H3K9ac on chromatin in living cells, HeLa cells were
loaded with FabH3K9ac-488, cultured for 4h, and then
ﬁxed with paraformaldehyde for immunostaining with the
same mAb labeled with Cy3 (IgGH3K9ac-Cy3).
FabH3K9ac-488 and IgGH3K9ac-Cy3 were colocalized
outside DAPI-dense heterochromatin (Figure 1D), con-
sistent with H3K9ac being an active chromatin mark,
although FabH3K9ac-488 was distributed more diffusely
due to an unbound fraction. This result indicates that
FabH3K9ac is concentrated in H3K9ac-rich chromatin
in living cells. Since IgGH3K9ac-Cy3 could still bind to
the same modiﬁcations post-ﬁxation, the binding sites
appear to be unsaturated.
To investigate whether FabH3K9ac binds to its epitope
transiently or permanently, its mobility was investigated
by ﬂuorescence recovery after photobleaching (FRAP)
(10). In cells loaded with FabH3K9ac-488, a small spot
was bleached and the rate of ﬂuorescence recovery was
measured. As the recovery t1/2 was 8.7s (Figure 2),
FabH3K9ac did not appear to permanently block its
epitope from accessing other cellular proteins. This
binding time was shorter than that of phosphorylated
H3 Ser10 (H3S10ph)-speciﬁc Fab (residence time  44s)
(10) and a CpG-methylated DNA speciﬁc probe ( 20s)
(22), both of which have proven useful for live imaging
without affecting cell growth and embryo development
(8). Consistently, FabH3K9ac did not appear to be toxic
for cells. After Fab loading, HeLa cells went through a
few cell divisions over 40h (Figure 1E and Movie 3 in
Supplementary Data) and mouse preimplantation
embryos developed to birth like controls (Table 2) (20).
Taken together with the above immunoﬂuorescence data
showing that not all H3K9ac is occupied by FabH3K9ac
(Figure 1D), this suggests that Fab-binding is transient
and does not saturate available binding sites. For these
reasons, Fabs do not appear to block the association of
other cellular proteins to H3K9ac, which may explain the
lack of a detrimental phenotype in Fab-loaded cells.
Visualizing methylated histone H3K4 in living cells
Fab-based live endogenous modiﬁcation labeling
(FabLEM) was also applied to methylated H3K4 using
Fabs speciﬁc to monomethylation (FabH3K4me1,
prepared from CMA302), dimethylation (FabH3K4me2,
prepared from CMA303) and trimethylation
(FabH3K4me3, prepared from CMA304) (11).
When loaded into HeLa cells expressing H2B-mRFP
(for visualizing chromatin), FabH3K4me2-488 exhibited
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from H2B-mRFP-rich heterochromatin (Supplementary
Figure S2). This is consistent with the notion that
H3K4me2 is an active epigenetic mark (3,11). Similarly,
when FabH3K4me2-488 was simultaneously loaded with
another active marker FabH3K9ac-Cy5 into HeLa cells,
there was considerable overlap between the two signals in
euchromatic regions depleted in H2B-mRFP-rich hetero-
chromatin (Figure 3A).
The cytoplasmic concentration of FabH3K4me2 was
greater than FabH3K9ac (Figure 3A). This can be ex-
plained by its lower epitope binding afﬁnity measured
in vivo by FRAP and in vitro by surface plasmon reson-
ance using BIACORE. Speciﬁcally, the FRAP recovery
time of FabH3K4me2 was signiﬁcantly faster (t1/2 1.2s)
than FabH3K9ac (t1/2 8.7s) (Figure 2A) and the binding
dissociation constant signiﬁcantly higher (KD 1.1 10
 8
M versus 4.4 10
 11 M; Table 1).
In living HeLa cells, FabH3K4me1-488 and
FabH3K4me3-488 were also concentrated in the nucleus
over the cytoplasmic background; however, their distribu-
tion was less punctate in living cells compared to immuno-
ﬂuorescence signals by ﬁxed cells (Supplementary Figure
S2). This is probably due to the weaker epitope-binding
afﬁnity, indicated by the slightly faster FRAP recovery
(Supplementary Figure S3), and/or less abundance of the
target modiﬁcation. Although these antibodies may not be
suitable for visualizing the subnuclear localization of
modiﬁcations at a high resolution, they can be used for
monitoring global modiﬁcation levels, as described below.
Visualizing methylated histone H3K9 in living cells
To visualize histone H3K9 methylation, we prepared Fabs
from newly developed mAbs, which worked better for
chromatin immunoprecipitation (13) than previously pub-
lished mAbs (11). FabH3K9me1 and FabH3K9me2 were
successfully prepared from CMA316 and CMA317, as
were other Fabs. However, active FabH3K9me3 could
not be prepared by the standard protease digestion
methods using either papain or ﬁcin because CMA318
contained protease susceptible sites in the heavy chain
Fab region (Supplementary Figure S4). FabH3K9me1
distributed nearly homogenously in the nucleus, excluding
nucleoli (Supplementary Figure S2), reﬂecting the broad
distribution of H3K9me1 (11) and the presence of a large
free pool (indicated by its very rapid FRAP recovery;
Figure 1. Histone H3K9 acetylation is visualized in living cells.(A) Schematic drawing showing how histone modiﬁcations are visualized in living
cells. In the upper path, modiﬁcation-speciﬁc mAb (IgG) is directly conjugated with a ﬂuorescent dye, loaded into the cytoplasm and targeted to
nuclear epitopes after cell division. In the lower path, illustrating FabLEM, an additional digestion step is required to make Fab, but targeting to
nuclear epitopes takes less than an hour. (B and C) Distribution of Alexa488-labeled H3K9ac speciﬁc IgG and Fab. HeLa cells were loaded with
IgGH3K9ac-488 (B) or FabH3K9ac-488 (C), and ﬂuorescence images collected every 30 or 5min (Movies 1 and 2 in Supplementary Data). (D)
FabH3K9ac-488 loaded in living HeLa cells distributed similarly to IgGH3K9ac-Cy3 in ﬁxed cells. Confocal images are shown. (E) Time lapse
imaging of HeLa cells loaded with FabH3K9ac-488 through multiple cell divisions (Movie 3 in Supplementary Data). Bars, 10mm.
Nucleic Acids Research, 2011,Vol.39, No. 15 6479Supplementary Figure S3). Therefore, we focused on
FabH3K9me2 for localization studies.
Histone H3K9me2 is a repressive mark in euchromatin
and facultative heterochromatin (3,23). Consistent with
this notion, when FabH3K9me2 was loaded into living
HeLa cells, it overlapped considerably with H2B-mRFP
(Supplementary Figure S2), in contrast to the active marks
examined earlier. Similarly, when FabH3K9me2-488 was
simultaneously loaded with an active marker FabH3K9ac-
Cy5, there was little overlap in signal (Figure 3A), even
though binding was rapid (FRAP t1/2 1.1s, Figure 2;
KD 1.5 10
 8 M, Table 1).
To validate whether the localization of FabH3K9me2
depended on H3K9me2, conditional G9a methyltransfe-
rase knockout cells (17) were used (Figure 3B). Mouse
embryonic stem cells expressing or lacking G9a, which is
responsible for H3K9 dimethylation (23), were loaded
with FabH3K9me2-488 and FabH3K9ac-Cy3. Whereas
FabH3K9me2 was localized to nuclear foci in control
cells, it was diffuse in G9a-knockout cells. In contrast,
H3K9ac was localized to the nucleus in both cells. This
result directly demonstrates that FabH3K9me2 is concent-
rated on H3K9me2-enriched chromatin in living cells.
Visualizing trimethylated H3K27 for monitoring the
dynamics of inactive X chromosomes in living cells
H3K27me3 is known to be enriched on inactive X
chromosomes, which are often located near the nuclear
periphery or around nucleoli in ﬁxed female cells (24). In
living cells, FabH3K27me3-488 was also concentrated on
inactive X chromosomes, exhibiting single foci in normal
female ﬁbroblasts (46, XX) and two and three foci in
Klinefelter Syndrome cells (X trisomy and tetrasomy, re-
spectively) (Figure 3C, arrows). In contrast, such obvious
concentrations were not observed in cells harboring only
one active X, like male (46, XY) and Turner syndrome
(45, XO) cells (Figure 3C and not shown). Thus, the
number of FabH3K27me3 foci corresponded to that of
inactive X. Simultaneous loading of FabH3K27me3-488
and FabH3K27ac-Cy3, which is enriched on active tran-
scription start sites (11), revealed that FabH3K27ac
was excluded from FabH3K27me3-enriched inactive X
in living cells (Figure 3D, arrows), consistent with the
transcriptional repression state of inactive X. The FRAP
recovery time of FabH3K27me3 (0.94s) was similar
in range to FabH3K4me2 and FabH3K9me2, whereas
FabH3K27ac exhibited more stable binding (21s)
(Figure 2). This again correlated with their epitope-
binding afﬁnity in vitro (KD 1.2 10
 8 and
1.4 10
 12M for FabH3K27me3 and FabH3K27ac, re-
spectively; Table 1).
To visualize the dynamics of inactive X chromosomes
during the cell cycle, hTERT-RPE1 cells (46, XX) were
loaded with FabH3K27me3-488 and PCNA-Cy3
(Cy3-labeled proliferating cell nuclear antigen), which
highlighted DNA replication foci during S phase as did
GFP-tagged PCNA (25). Live imaging conﬁrmed that
inactive X replicates very late in S phase (Figures 3E, 6
and 8h and Movie 4 in Supplementary Data). Whereas
previous work suggested inactive X chromosomes dynam-
ically move from the nuclear periphery to perinucleoli
during S phase (26), inactive X appeared to be replicated
without changing its intranuclear positioning (Figure 3E,
arrows). Such static behaviors of inactive X were also
observed in other cell types like WI-38 ﬁbroblasts and
cervical squamous cell carcinoma cells (not shown), sug-
gesting that the perinucleolar targeting is not essential for
maintaining the inactive state of X chromosomes during/
after replication. Similarly, autosomes are also reported to
exhibit no large-scale redistribution in the nucleus in
HT-1080 cells during G1 phase (27).
Quantitative measurement of changes in histone
modiﬁcation levels in living cells
Beyond detecting modiﬁcations at speciﬁc locations,
FabLEM can also be used to monitor global modiﬁcation
Figure 2. Kinetics of Fabs in living cells. (A) FRAP examples. A small
area (2mm diameter) is bleached and the ﬂuorescence intensity in the
bleached area is measured. Bar, 10mm. (B) FRAP results. The relative
intensity of bleached area for the indicated Fabs was plotted (averages
of >15 cells) with the recovery t1/2.
Table 2. Full-term development of embryos injected with FabH3K9ac
and subjected to long-term imaging
Fab Imaging
a No. of
embryos
transferred
No. (%)
of pups
FabH3K9ac (200mg/ml)   80 26 (32.5)
b
+ 40 16 (40.0)
b
Embryos generated by in vitro fertilization were injected with
FabH3K9ac-488 together with 5mg/ml of H2B-mRFP mRNA,
imaged up to the morula/blastocyst stage ( 70h post-insemination),
and then transferred to the uterus on Day 2.5 post-coitum
pseudopregnant females.
aImaging minus means the embryos were injected with antibody but not
imaged.
bThe efﬁciency of birth rate is in a range of controls without
injection (20).
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of the nuclear to cytoplasmic Fab concentration is useful
(Figure 4A). In essence, the nuclear concentration is
correlated with the amount of bound Fab, whereas the
cytoplasmic concentration is correlated with the amount
of freely diffusing unbound Fab. Thus, when the level of
modiﬁcations increase within the nucleus, so too does the
nucleus:cytoplasm ratio of Fab.
To demonstrate, FabH3K27ac-Cy3 was loaded into
living cells to investigate the effect of an HDAC inhibitor,
trichostatin A (TSA). When TSA was added at a ﬁnal
concentration of 1mM, the nucleus:cytoplasm ratio of
FabH3K27ac intensity increased within 30min and this
trend continued for at least 2h (Figure 4B, C and Movie
5 in Supplementary Data). This observation is consistent
with the hyperacetylation of H3K27 induced by TSA
treatment (11). The effect of TSA was detected at concen-
trations as low as 10nM (Figure 4C and D). This sensi-
tivity appears to be lower than that of a recently developed
FRET-based probe for histone H4 acetylation (9), but a
direct comparison is difﬁcult as the target acetylation sites
are different (H3K27 versus H4K5/8).
Live imaging also revealed that a higher concentration
of TSA (3.3mM) affected H3K9 dimethylation levels.
HeLa cells were loaded with FabH3K9me2-488,
FabH3K9ac-Cy5 and PCNA-Cy3, and imaged under a
Figure 3. Localization of methylated histone H3 in living cells. (A–D) Confocal microscope images of living cells. (A) H2B-mRFP-expressing HeLa
cells loaded with FabH3K4me2-488, or FabH3K9me2-488, together with FabH3K9ac-Cy3. (B) Nuclear concentration of FabH3K9me2 is diminished
in G9a knockout ES cells. FabH3K9me2-488 and FabH3K9ac-Cy3 were loaded into conditional G9a knockout ES cells before (top) and after
(bottom) the gene deletion. (C) FabH3K27me3 is concentrated in inactive X chromosomes. Arrows indicate FabH3K27me3 foci. (D) Mouse MC12
cells loaded with FabH3K27me3-488 and FabH3K27ac-Cy3. Arrows indicate FabH3K27me3 foci. (E) Behavior of inactive X chromosomes during S
phase. hTERT-RPE1 cells were loaded with FabH3K27me3-488 and PCNA-Cy3, and phase contrast and wide-ﬁeld ﬂuorescent images were collected
every 15min (Movie 4 in Supplementary Data). Arrows indicate FabH3K27me3-enriched inactive X chromosomes. Bars, 10mm.
Nucleic Acids Research, 2011,Vol.39, No. 15 6481Figure 4. Monitoring the levels of histone H3 modiﬁcations in living cells. (A) Schematic drawing showing how modiﬁcation levels are monitored in
living cells using Fab. The nuclear concentration of Fab, or the intensity ratio of nucleus:cytoplasm, reﬂects the level of the target modiﬁcation.
(B–D) Monitoring H3K27ac levels in living U2OS cells. Cells loaded with FabH3K27ac-Cy3 were imaged every 15min, and TSA was added (Movie
5 in Supplementary Data). Shown are pseudo-color images (B) and the ﬂuorescent intensity ratio of nucleus:cytoplasm (C and D); (C) the average
(n>8); (D) the value of nucleus:cytoplasm at 2h normalized to its value at 0h in individual cells. Asterisks indicate P<0.005 by two-tailed Student’s
t-test; actual P-values are: 1nM, 0.178; 3.3nM, 0.166; 10nM, 0.00016; 33nM, 0.0023; 100nM, 0.00078; 333nM, 0.0022; and 1000nM, 0.0000037. (E–
H) Effects of TSA on H3K9 acetylation and methylation levels in HeLa cells. Cells were loaded with FabH3K9ac-Cy5, PCNA-Cy3 and
FabH3K9me2-488 (E, F, H) or FabH3K9me1-488 (G), imaged every 15min, and TSA (3.3mM) was added. (E) Fluorescent images (Movie 6 in
Supplementary Data). (F and G) The intensity ratio of nucleus:cytoplasm (averages with SD; n=10). (H) The ratio of chromatin-bound:free
FabH3K9me2 in individual cells. P-values by two-tailed Student’s t-test are indicated. (I and J) Monitoring H3K9ac and H3K9me2 levels after
the removal of TSA. HeLa cells loaded with FabH3K9me2-488 and FabH3K9ac-Cy3 were imaged every 30min, TSA (3.3mM) was added at time
point 0 and removed 3h later. (I) Pseudo-color images of ﬂuorescence intensity (see Movie 7 in Supplementary Data for gray scale and merged
images). (J) The intensity ratio of nucleus:cytoplasm (averages with SD; n=10). Bars, 10mm.
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perinucleolar concentration of FabH3K9me2 gradually
decreased, as did the overall nuclear concentration
(Figure 4E, F and Movie 6 in Supplementary Data). In
contrast, the nuclear concentration of FabH3K9ac incr-
eased. FabH3K9me1 behaved similarly, spreading more
to the cytoplasm in the presence of TSA (Figure 4G).
TSA-induced H3K9 demethylation was observed in most
cells, including ones outside S phase without PCNA foci
(Figure 4E). This indicates that the inhibition of deacety-
lation induces H3K9 demethylation independently of
DNA replication. These TSA-induced changes in H3K9
modiﬁcation levels were also monitored by measuring
the chromatin-bound fraction of Fab using FRAP (28)
(Supplementary Figure S5). Consistent with the intensity
ratio measurements (Figure 4F), the chromatin-bound
fraction of FabH3K9ac increased in TSA for 3h,
whereas that of FabH3K9me2 decreased (Figure 4H).
This demonstrates that the relatively easy-to-measure
nucleus:cytoplasm ratio is appropriate for monitoring
bound Fab.
We then investigated whether H3K9ac and H3K9me2
levels are restored after the removal of TSA. HeLa cells
were loaded with FabH3K9ac-Cy3 and FabH3K9me2-
488, incubated in 3.3mM TSA for 3h, washed with fresh
medium, and further incubated in the absence of TSA. As
seen before, the nuclear concentrations of FabH3K9ac
and FabH3K9me2 increased and decreased, respectively,
in the presence of TSA (Figure 4I, J and Movie 7 in
Supplementary Data). Within 2h after TSA removal, the
nuclear intensity of FabH3K9ac dropped to the original
level; in contrast, the nuclear intensity of FabH3K9me2
gradually increased but did not reach its original level in
3h (Figure 4I, J and Movie 7 in Supplementary Data).
Thus, deacetylation results in an increase in dimethyla-
tion, suggesting that H3K9 acetylation antagonizes di-
methylation. Although it is interesting to monitor when
the original H3K9me2 level is restored in long-term moni-
toring, many cells went into mitosis during the observa-
tion period, making quantitative analysis difﬁcult.
Perhaps the use of cells that grow more slowly will help
address this question in a future study.
Effects of TSA on histone H3K4 methylation
It has been shown that HDAC inhibitor treatments result
in an increase in H3K4 methylation, in addition to H3 and
H4 acetylation (29,30). We thus used FabLEM to investi-
gate the effects of TSA on histone H3K4 methylation.
Soon after the addition of TSA, both FabH3K4me2 and
FabH3K4me3 accumulated in the nucleus (Figure 5A and
B). This is consistent with previous studies (29,30). In
contrast, the nuclear intensity of FabH3K4me1 slightly
decreased (Figure 5B). Although a long-term study sug-
gested HDAC inhibitors could indirectly affect H3K4
methylation levels by altering H3K4 demethylase expres-
sion (30), here real-time monitoring by FabLEM demonst-
rated a rapid increase in H3K4me2, supporting the idea
that cross-talk between H3 acetylation and H3K4 methy-
lation is more direct and occurs through multienzyme
complexes (29).
Monitoring histone H3 acetylation in mouse
preimplantation embryos
FabLEM was next used to monitor histone H3 modiﬁca-
tions in mouse preimplantation embryos, where dynamic
epigenetic changes are known to take place (5).
Fluorescently labeled Fab together with mRNA encoding
histone H2B-mRFP were injected into eggs produced by
in vitro fertilization (IVF) or intracytoplasmic sperm injec-
tion (20) (Figure 6A). Among the Fabs investigated, only
H3 acetylation-speciﬁc Fabs were concentrated in
pronuclei, whereas methylation speciﬁc Fabs distributed
throughout the egg cytoplasm even though some concen-
tration of FabH3K27me3 was observed on condensed
chromosomes during mitosis (Supplementary Figure S6).
This suggests that higher epitope-binding afﬁnities may be
needed for monitoring interphase nuclei in mouse
embryos.
When injected into IVF embryos, FabH3K9ac was
concentrated in both maternal and paternal pronuclei,
Figure 5. Effects of TSA on H3K4 methylation levels. HeLa cells were loaded with FabH3K9ac-Cy5 and FabH3K4me1-488, FabH3K4me2-488, or
FabH3K4me3-488, imaged every 15min, and TSA (3.3mM) was added. (A) Images of phase-contrast, FabH3K4me2-488 and FabH3K9ac-Cy3. Bar,
10mm. (B) The intensity ratio of nucleus:cytoplasm (averages with SD; n=10).
Nucleic Acids Research, 2011,Vol.39, No. 15 6483Figure 6. Monitoring the levels of histone H3 acetylation in living mouse preimplantation embryos. (A and B) Schematic drawing of mouse embryo
imaging. (A) FabLEM perfomed on eggs with in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI). Oocytes were fertilized in vitro,
injected with a mixture of ﬂuorescently labeled Fab and histone H2B-mRFP1 mRNA at anaphase II-telophase II stage, and then placed on the
imaging system. After the imaging, morula–blastocyst stage embryos were transferred to the uterus of the recipient pseudopregnant mothers. (B)
FabLEM perfomed on embryos with somatic cell nuclear transfer (SCNT). Metaphase II stage oocytes were injected with a mixture of ﬂuorescently
labeled Fab and histone H2B-mRFP1 mRNA, enucleated, and injected with a somatic nucleus derived from a cumulus cell. The reconstructed
embryos were activated with SrCl2 and cytochalasin B (±50nM TSA) for 6h. The embryos were further incubated (±50nM TSA) for 3h. (C–F)
Monitoring the levels of histone H3 acetylation. Time-lapse confocal images were acquired for IVF and SCNT (±TSA treated) embryos injected
with FabH3K9ac-488 (C and D; Movie 8 in Supplementary Data), or FabH3K27ac-488 (E and F; Movie 9 in Supplementary Data), and mRNA
encoding H2B-mRFP. Typical images before and after the ﬁrst division are shown in (C) and (E). The intensity ratio of nucleus to cytoplasm was
measured and the averages (n>10) are plotted (D and F). Bars, 10mm.
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in Supplementary Data). The higher level of H3K9ac in
paternal pronuclei may be consistent with the absence of
H3K9 methylation on paternal chromatin in zygotes (5).
The H3K9ac level was relatively constant throughout
zygotic and two-cell stages in IVF embryos (Figure 6D,
blue symbols). FabH3K27ac was also concentrated
more in paternal pronuclei, but its level was gradually
and substantially decreased in zygotes before the ﬁrst
mitosis (Figure 6E and F, blue symbols; Movie 9 in
Supplementary Data). This active deacetylation may be
complementary, or prerequisite, to de novo H3K27 methy-
lation on paternal pronuclei in zygotes (5). The distinct be-
haviors of H3K9ac and H3K27ac were directly compared
by injecting two Fabs conjugated with different dyes (i.e.
FabH3K9ac-488 and FabH3K27ac-Cy3) (Supplementary
Figure S7). As seen above, H3K27ac levels decreased in
zygotes. Inhibition of HDACs by TSA caused different
effects on H3K9ac and H3K27ac. In the presence of
TSA, the level of H3K9ac continuously increased during
zygotic and two-cell stages more than in untreated
embryos; in contrast, TSA prevented the decrease of
H3K27ac levels (Supplementary Figure S7). Thus, TSA
treatments induced hyperacetylation of H3K9 and pre-
vented deacetylation of H3K27, suggesting that the acetyl-
ation of these sites is differentially controlled in mouse
preimplantation embryos.
HDAC inhibitors like TSA are known to improve the
efﬁciency of embryo development after somatic cell nuclear
transfer (SCNT), but the mechanism of HDAC inhibitor’s
effect remains unknown (12). Using FabLEM, H3 acetyl-
ation levels in SCNT embryos and the effect of TSA treat-
ments were measured. Enucleated oocytes were injected
with somatic cell nuclei, treated with or without TSA for
9h during the activation, and then allowed to develop
in TSA-free medium under a confocal microscope
(Figure 6B). The levels of H3K9ac in SCNT embryo
nuclei were similar to that in IVF pronuclei, and became
higher upon TSA treatment (Figure 6C and D). In
contrast, the levels of H3K27ac in SCNT embryo nuclei
were much lower, but increased to the maternal pro-
nuclear level upon TSA treatment (Figure 6E and F).
These results suggest that different levels of H3K27ac
between IVF pronuclei and SCNT embryo nuclei may at
least partially account for their different development
efﬁciencies.
DISCUSSION
This study demonstrates that FabLEM can be used to
monitor the concentration of epigenetic histone modiﬁca-
tions such as histone H3 acetylation and methylation in
living somatic cells and preimplantation embryos. Under
appropriate conditions, FabLEM did not affect cell
growth and mouse embryo development. This implies
the method does not disturb normal cell metabolism, pre-
sumably because monovalent Fabs only bind their targets
transiently, so other cellular proteins maintain access to
their binding sites. Fab-based live cell imaging was also
used to visualize endogenous proteins in Drosophila
embryos, apparently without disturbing the nuclear div-
isions (31,32).
In this study, we used fully characterized and highly
speciﬁc mAbs (11,13) for FabLEM. In general,
high-speciﬁc antibodies must be used for FabLEM
because there is no blocking reagent that could suppress
non-speciﬁc binding, unlike immunostaining for ﬁxed
cells. Although Fab prepared from antigen
afﬁnity-puriﬁed polyclonal antibody may sufﬁce for
FabLEM, the preparation is likely to contain various frag-
ments with different afﬁnities due to its polyclonal nature.
Considering the importance of Fab afﬁnity as described
below, monoclonal antibodies are recommended for better
control of FabLEM experiments.
Fab afﬁnity is an important factor for the quality,
versatility and interpretation of FabLEM
Whereas all methyl-speciﬁc Fabs we tested were adequate
for live-imaging in cultured cells, only acetyl- and
phospho-speciﬁc Fabs were successful for imaging in
preimplantation embryos [this study and (10)]. This
could be explained by the different afﬁnities of Fabs,
because all methyl-speciﬁc Fabs exhibit much shorter
FRAP recoveries ( 1s) than acetyl- and phospho-speciﬁc
Fabs (>8s); the residence time of Fabs does not appear to
represent the turnover of the modiﬁcation as H3K9
methylation is more stable than acetylation (33). Since
the cytoplasmic volume of preimplantation embryos
( 270pl; calculated from its diameter 80mm) is more
than 50-fold larger than that of HeLa cells [ 5pl; (10)],
imaging with sufﬁcient contrast may require high afﬁnity
Fabs. As a rule of thumb, mAbs with KD  10
 8M can be
adequate for FabLEM, but high afﬁnity ones with
10
 11 10
 12M will yield higher contrast images and gen-
erally be more versatile (contingent on the abundance of
the endogenous target).
Some limitations of the FabLEM technique should be
considered. First, the time resolution of FabLEM depends
on the binding time of Fab. For example, changes in less
than a few seconds cannot be followed using a high
afﬁnity Fab, like FabH3K9ac with toff  7.3s
(Supplementary Figure S5). Second, it is also possible
that the turnover of modiﬁcation is inﬂuenced by Fab
binding and so the balance of modiﬁcation–
demodiﬁcation may be disturbed, even though such a
change may not signiﬁcantly affect biological function of
cells and embryos. This issue can be addressed by using
two Fabs with the same speciﬁcity but with different
afﬁnities, since lower afﬁnity Fabs should have better
temporal resolution and should minimize blocking
effects (at the cost of enhanced signal-to-noise).
Fabs repeatedly bind and unbind their target modiﬁca-
tions in nuclei. As unbound Fabs can diffuse into the
cytoplasm, the ratio of nuclear and cytoplasmic Fab in-
tensity is correlated with that of bound and unbound frac-
tions. Since the nucleus:cytoplasm ratio depends on both
Fab afﬁnity and the abundance of target modiﬁcation, the
degree of changes among different Fabs cannot be directly
compared. The intensity measurements, for example,
revealed that after the addition of TSA the level of
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H3K9me1. This does not necessarily mean, however,
that H3K9me2 is changed more signiﬁcantly, because
the dynamic range of FabH3K9me1 is lowered by the
presence of a larger unbound fraction. Similarly, it is
also difﬁcult to conclude which state of H3K4 methylation
(di or tri) is more increased in TSA. These types of more
quantitiative comparisons will require knowledge of the
absolute amount of each modiﬁcation as well as further
biophysical characterization of Fabs in living cells.
FabLEM for visualizing modiﬁcation sites
As discussed above, Fabs with a wide range of epitope
binding afﬁnities can be used to monitor changes in
target modiﬁcation levels. Visualization of the modiﬁca-
tion sites, however, depends not only on the Fab afﬁnity
but also on the distribution and concentration of the
modiﬁcation. When a speciﬁc modiﬁcation is massively
enriched in large foci, Fabs can be concentrated locally,
even if their afﬁnity is not very high. In this case, the foci
can be detected under a conventional wide-ﬁeld micro-
scope, like FabH3K27me3 on inactive X chromosomes.
If the modiﬁcation is scattered at numerous small foci
throughout the nucleus, however, a high afﬁnity Fab
combined with a high resolution system (like confocal or
deconvolution microscopy) is required. This is exempliﬁed
by H3K4me3 and H3K27ac, both of which exhibit a
number of small foci in ﬁxed and immunolabeled nuclei
(Supplementary Figure S2). In FabLEM using a confocal
microscope, FabH3K4me3 distributed diffusely, whereas
FabH3K27ac is concentrated in foci, reﬂecting the differ-
ences in their afﬁnity.
A role for H3K27 acetylation in mouse embryo
development
We applied FabLEM to monitor the changes of H3K9
and H3K27 acetylation in mouse preimplantation
embryos. During embryo development, DNA methylation
and histone modiﬁcations change drastically (5,7). After
fertilization, sperm chromatin is decondensed by replacing
protamines with maternal histones in egg cytoplasm. The
newly assembled histones in paternal pronuclei are gener-
ally associated with acetylation without methylation, in
contrast to histones in maternal pronuclei in which repres-
sive methylation marks are inherited from oocytes.
Indeed, FabLEM revealed both H3K9 and H3K27 acetyl-
ation levels are higher in paternal pronuclei. While the
H3K9ac level remains relatively constant throughout
zygote and two-cell stages, H3K27ac in paternal pronuclei
is substantially reduced in zygotes. Furthermore, the
H3K27ac level in somatic nuclei transferred into oocytes
is much lower than pronuclei in zygotes, but is increased
by histone deacetylase inhibitor treatments, which are
known to increase the cloning efﬁciency of SCNT
embryos (12). These data suggest that a high level of
H3K27ac is important for normal embryo development,
by antagonizing the methylation on the same lysine
residue (34–36). Lower acetylation levels observed in
transferred somatic cell nuclei might establish an
abnormal epigenetic landscape, which in turn might
cause aberrant gene expression proﬁles. Increased levels
of H3K27ac by TSA may thus be a factor that contributes
to the normal development of SCNT embryos. Indeed, the
global level of transcription in two-cell SCNT embryos
was shown to increase upon TSA treatment (37). In
contrast, H3K9ac does not appear to have much antag-
onistic effect on methylation in zygotes, since H3K9me1
and H3K9me2 are observed in paternal pronuclei before
the ﬁrst division (5,34) despite the constant levels of
H3K9ac.
Concluding remarks and future prospects
Besides FabLEM, real-time measurements of protein
modiﬁcation levels in living cells can also be achieved
using FRET-based sensors (2,8,9). Although a direct com-
parison of these two methods has yet to be made,
FabLEM generally has the following advantages: (i) en-
dogenous modiﬁcations can be monitored; (ii) standard
single-color ﬁlter sets can be used for ﬂuorescence
imaging; (iii) many antibodies are available for simultan-
eous detection of different modiﬁcations in the same cells;
and (iv) no genetic or recombinant material is introduced,
so imaged cells and embryos can act as donors for repro-
duction studies, although long-term experiments might be
hampered by dilution of Fabs upon cell division. The re-
quirement of protein loading into living cells might be
considered a drawback of FabLEM as microinjection is
tedious and other methods are not as standard as
DNA-mediated expression systems; however, many
different techniques and reagents have been developed
for protein delivery into cells and tissues (38), pos-
sibly making it much easier to use FabLEM in the
future. Alternatively, the expression of GFP-fused
antigen-binding fragments, like single-chain Fabs,
single-chain variable fragments, or chromobodies,
might complement the limitations of protein-based
methods (39).
In conclusion, we anticipate FabLEM will be a
powerful tool for monitoring the dynamic changes of epi-
genetic modiﬁcations during the cell and developmental
cycles and in response to stimuli and small chemicals.
The method can be used to visualize any endogenous
protein modiﬁcation, providing a novel strategy to under-
stand the dynamic nature of cell regulation and test the
response of patient cells to potentially therapeutic drugs.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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